Project: Accelerating next-generation probiotic innovation with a novel modular product development platform
| Acronym | NOVOBIOME (Reference Number: 113425) |
| Duration | 01/10/2019 - 03/10/2022 |
| Project Topic | Modulating the microbiota with probiotics is a revolutionary approach to prevent, mitigate and cure non-communicable diseases (NCDs). Current probiotics were selected for scalability but breakthrough innovation depends on novel, microbiota-derived species that are inherently difficult to cultivate, characterize and produce. NOVOBIOME will accelerate the time-to-market of breakthrough innovations by enabling effective, economically viable product development in a modular development platform. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 11 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | Winclove B.V. | Coordinator | Netherlands |
| 2 | ProDigest BVBA | Partner | Belgium |
| 3 | VivaCell Biotechnology GmbH | Partner | Germany |
| 4 | Wageningen University, Department Agrotechnology and Food Sciences | Partner | Netherlands |
| 5 | Universitair Medisch Centrum Groningen | Partner | Netherlands |